We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+13.35%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$695M
AUM Growth
-$484M
(-41%)
Cap. Flow
-$523M
Cap. Flow
% of AUM
-75.27%
Top 10 Holdings %
Top 10 Hldgs %
42.72%
Holding
112
New
21
Increased
7
Reduced
35
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$15.5M |
| 2 |
Mastercard
MA
|
+$11.5M |
| 3 |
Corteva
CTVA
|
+$10.9M |
| 4 |
Tandem Diabetes Care
TNDM
|
+$9.16M |
| 5 |
SentinelOne
S
|
+$8.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$24.1M |
| 2 |
Liberty Media Series C
FWONK
|
+$20.6M |
| 3 |
Amazon
AMZN
|
+$19.8M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$15M |
| 5 |
CrowdStrike
CRWD
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.62% |
| 2 | Technology | 31.8% |
| 3 | Communication Services | 10.64% |
| 4 | Industrials | 5.28% |
| 5 | Materials | 2.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Calix
CALX
$2.27B
| $44.9M | 6.46% |
656,173
-143,927
| -18% | -$9.67M |
|
2
Impinj
PI
$3.89B
| $39.6M | 5.7% |
363,000
+23,000
| +7% | +$2.42M |
|
3
Clearfield
CLFD
$421M
| $39.2M | 5.63% |
416,100
+54,094
| +15% | +$5.7M |
|
4
Inspire Medical Systems
INSP
$1.42B
| $35.5M | 5.1% |
140,865
-12,637
| -8% | -$2.69M |
|
5
Enphase Energy
ENPH
$4.84B
| $32M | 4.6% |
120,700
+1,000
| +0.8% | +$291K |
|
|
SWAV
6
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $25.2M | 3.62% |
122,593
-10,182
| -8% | -$2.57M |
|
|
7
Liberty Media Series C
FWONK
$24.3B
| $22.2M | 3.2% |
384,756
-359,415
| -48% | -$20.6M |
|
8
T-Mobile US
TMUS
$193B
| $20.7M | 2.98% |
147,829
-30,171
| -17% | -$4.33M |
|
9
Intuitive Surgical
ISRG
$121B
| $19.1M | 2.75% |
72,000
-5,500
| -7% | -$1.34M |
|
10
Acadia Healthcare
ACHC
$3.17B
| $18.7M | 2.69% |
226,939
-58,061
| -20% | -$4.79M |
|
11
Axsome Therapeutics
AXSM
$12.4B
| $17.5M | 2.51% |
226,535
-37,795
| -14% | -$2.26M |
|
|
12
DexCom
DXCM
$27.6B
| $16M | 2.31% |
+141,635
| New | +$15.5M |
|
13
Repligen
RGEN
$7.44B
| $15.7M | 2.26% |
92,761
+8,761
| +10% | +$1.59M |
|
14
United Therapeutics
UTHR
$26.3B
| $15.1M | 2.18% |
54,412
+1,412
| +3% | +$356K |
|
15
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
| $14.7M | 2.12% |
+1,500
| New | +$143K |
|
16
Jazz Pharmaceuticals
JAZZ
$15.9B
| $14.2M | 2.05% |
89,407
-40,593
| -31% | -$5.95M |
|
|
VISN
17
Vistance Networks Inc
VISN
$2.66B
| $13.7M | 1.98% |
1,869,900
-730,100
| -28% | -$7.04M |
|
18
Netflix
NFLX
$292B
| $12.4M | 1.78% |
420,000
-70,000
| -14% | -$1.96M |
|
19
Microsoft
MSFT
$2.84T
| $12.2M | 1.75% |
50,800
| – | – |
|
|
20
Mastercard
MA
$477B
| $12.2M | 1.75% |
+35,000
| New | +$11.5M |
|
|
AVID
21
DELISTED
Avid Technology Inc
AVID
| $10.5M | 1.51% |
395,602
-167,079
| -30% | -$4.4M |
|
22
argenx
ARGX
$57.4B
| $10.4M | 1.5% |
27,521
-8,479
| -24% | -$3.17M |
|
|
23
Corteva
CTVA
$59.7B
| $10.2M | 1.46% |
+173,000
| New | +$10.9M |
|
|
KRTX
24
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $9.64M | 1.39% |
49,081
-41,919
| -46% | -$8.99M |
|
25
Martin Marietta Materials
MLM
$33.6B
| $9.56M | 1.38% |
28,300
-21,700
| -43% | -$7.4M |
|
Similar funds
AGA
ATS
RIM
ACM
CAM
LSA
GWA
Atika Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Atika Capital Management held 112 positions worth $695M, down 41% from $1.18B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Atika Capital Management withdrew a net $523M in Q4 2022, closing 47 positions and reducing 35 holdings. Its most notable exit was Palo Alto Networks, an estimated $24.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 25% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Atika Capital Management opened a new position in DexCom worth $16M.
- Atika Capital Management's largest Q4 2022 buy was DexCom: 141,635 shares worth $16M.
- Atika Capital Management added most to Clearfield in Q4 2022, an estimated $5.7M increase.
- Atika Capital Management's biggest Q4 2022 reduction was Liberty Media Series C, cutting an estimated $20.6M.
- Atika Capital Management fully exited Palo Alto Networks in Q4 2022, selling an estimated $24.1M.
- Atika Capital Management's ten largest holdings make up 43% of its $695M portfolio in Q4 2022.
- Atika Capital Management opened 21 new positions and closed 47 in Q4 2022.
- Atika Capital Management's portfolio value fell 41% quarter-over-quarter to $695M.
Based on Atika Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.